Someone with a lot of money to spend has taken a bullish stance on AbbVie ABBV.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for AbbVie.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $27,980, and 9, calls, for a total amount of $357,429..
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $165.0 for AbbVie over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $100.0 to $165.0 in the last 30 days.
AbbVie Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | BEARISH | 12/15/23 | $145.00 | $62.3K | 636 | 99 |
| ABBV | CALL | TRADE | BEARISH | 01/17/25 | $140.00 | $58.1K | 399 | 30 |
| ABBV | CALL | SWEEP | BULLISH | 10/27/23 | $100.00 | $37.8K | 2 | 56 |
| ABBV | CALL | SWEEP | BULLISH | 10/27/23 | $100.00 | $37.8K | 2 | 48 |
| ABBV | CALL | SWEEP | BULLISH | 02/16/24 | $155.00 | $36.0K | 536 | 90 |
Where Is AbbVie Standing Right Now?
- With a volume of 661,300, the price of ABBV is down -2.97% at $144.84.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 8 days.
What The Experts Say On AbbVie:
- Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $193.
- Raymond James downgraded its action to Outperform with a price target of $177
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
